HymonBio Co., Ltd. was established in 2015, with co-founders returning from the University of Texas and Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang Port, HymonBio has applied for 18 patents and obtained 6 authorized patents; 11 products have obtained Chinese medical device certificates; 2 products have obtained EU CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate.